Comparison of intravenous and intermittent furosemide injection on pulmonary status and heart failure of newborns
Phase 2
Recruiting
- Conditions
- Heart failure.Heart failure
- Registration Number
- IRCT20210317050737N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
All term newborn boys and girls, diagnosed with heart failure
Exclusion Criteria
Neonate with an age of more than 28 days, a birth weight of less than 1000 grams, severe electrolyte disorders and the presence of shock symptoms are excluded from the study.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Heart failure. Timepoint: Pulmonary function indicators and hemodynamic responses of infants will be reported every 4 hours and urinary output every 6 hours and at the end of every 48 hours after treatment with an average score. Method of measurement: Echocardiography.
- Secondary Outcome Measures
Name Time Method Treatment of heart failure. Timepoint: Pulmonary function indicators and hemodynamic responses of infants will be reported every 4 hours and urinary output every 6 hours and at the end of every 48 hours after treatment with an average score. Method of measurement: Echocardiography.